Impact of Lowering Phosphate Additive Intake on Metabolism and Cardiovascular Health in Community-Living Adults
1 other identifier
interventional
50
1 country
1
Brief Summary
The purpose of the study is to learn more about how common food additives can affect phosphorus metabolism in people with normal kidney function and people with chronic kidney disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable healthy
Started Aug 2015
Longer than P75 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 28, 2015
CompletedFirst Submitted
Initial submission to the registry
November 25, 2015
CompletedFirst Posted
Study publicly available on registry
December 3, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 5, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2020
CompletedMarch 11, 2021
March 1, 2021
4.5 years
November 25, 2015
March 10, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in circulating fibroblast growth factor 23 (FGF23) concentrations
Longitudinal change in FGF23 concentrations over 8 weeks
8 weeks
Change in brachial flow-mediated dilatation (FMD)
Longitudinal changes in FMD over 8 weeks
8 weeks
Change in pulse wave velocity (PWV)
longitudinal changes in PWV over 8 weeks
8 weeks
Study Arms (1)
single arm study
EXPERIMENTALInterventions
Eligibility Criteria
You may not qualify if:
- current smoking
- extreme obesity (BMI ≥ 35 kg/m2)
- pregnancy or breastfeeding
- conditions affecting phosphate metabolism (e.g., hyper- or hypothyroidism; irregular menses for menstruating women)
- current intake of medications that impact phosphate metabolism (high-dose vitamin D, chronic antacid use)
- current use of blood pressure medications
- abnormal serum phosphate (≥ 4.6 or \< 2.5 mg/dl) or calcium levels (≥ 10.6 or \< 8.5 mg/dl)
- severe anemia (hemoglobin \< 8 g/dl for women and \< 9 g/dl for men).
- Inability to receive weekly shipments of food at home.
- Requirement for any special diet other than a regular diet.
- clinical need for a low potassium, low sodium or low protein diet
- new or recent change (\<3 months) in dosage of medications known to impact vascular reactivity
- current smoking
- poorly controlled hypertension (≥160/100 mmHg)
- extreme obesity (BMI ≥ 35 kg/m2)
- +7 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Alabama
Birmingham, Alabama, 35294, United States
Related Publications (1)
Khan MB, Carnethon MR, Isakova T, Wolf M, Gutierrez OM. Effects of Lowering Dietary Phosphorus Additive Intake on Mineral Metabolism in Adults with and without CKD. Clin J Am Soc Nephrol. 2025 May 13;20(7):950-957. doi: 10.2215/CJN.0000000730.
PMID: 40359505DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Orlando Gutierrez, MD
University of Alabama at Birmingham
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 25, 2015
First Posted
December 3, 2015
Study Start
August 28, 2015
Primary Completion
March 5, 2020
Study Completion
March 30, 2020
Last Updated
March 11, 2021
Record last verified: 2021-03